Pulse Biosciences, Inc. (PLSE): Capital Expenditures
$315.0K
Year ended 2025-12-31
$290.0K
Trailing 12 months to 2026-06-30
-7.7%
3-year compound annual growth
-6.5%
5-year compound annual growth
+13.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $315.0K | +152.0% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $125.0K | +3.3% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $121.0K | -69.8% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $401.0K | -8.2% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $437.0K | -0.9% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $441.0K | -27.5% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $608.0K | +120.3% | 2022-03-31, From 2019-01-01 |
| 2018-12-31 | $276.0K | -89.2% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $2.55M | n/m | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $64.0K | -25.6% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $86.0K | n/a | 2018-03-16, From 2015-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $315.0K | +152.0% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $103.0K | -37.2% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $700.0K | -6.5% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2024-12-31 | $0 | -100.0% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $17.0K | -74.6% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $185.0K | -73.2% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.0K | -83.3% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $7.7K | -87.8% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $3.68M | n/m |
Compare PLSE, QTEX, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗